Investor Class Action Filed Against Acadia Healthcare Company, Inc. for Securities Fraud Violations
Company Name: Acadia Healthcare Company, Inc.
Court: United States District Court for the Middle District of Tennessee
Case Number: 18-cv-00988
Judge: The Hon. William L. Campbell, Jr
Class period: Between February 23, 2017 and October 24, 2017
Security Type: Securities

Case Background:

On March 14, 2018, the initial complaint in this securities class action was filed against Acadia Healthcare Company, Inc. (“Acadia” or the “Company”), and certain of Acadia’s directors, officers and underwriters, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act.  

The complaint alleged that throughout and before the class period, the defendants made numerous materially false and misleading statements and omissions to investors regarding Acadia’s business and operations, including by falsely stating that the quality of its U.K. operations gave the Company a “competitive strength,” which would drive future growth and profitability, and by issuing false and misleading guidance regarding the Company’s actual and projected 2017 revenue, earnings before interest, taxes, depreciation and amortization and earnings per share.

This securities class action lawsuit was brought on behalf of purchasers of Acadia publicly traded securities between February 23, 2017 and October 24, 2017, inclusive.

Current Status of Case:

On April 1, 2019, the lead plaintiff filed an amended complaint. The defendants filed a motion to dismiss the amended complaint on May 31, 2019. The defendants’ motion to dismiss is now fully briefed before the Court pending its decision. This action is still ongoing.

If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Kessler Topaz Meltzer & Check, LLP
James Maro, Esq. or Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087 1-844-887-9500 (toll free) or 1-610-667-7706
Or by e-mail at

Please complete this form relating to your transactions for Acadia Healthcare Company, Inc. (Nasdaq: ACHC) securities between February 23, 2017 and October 24, 2017, inclusive (the “Class Period”).

You may also contact James Maro, Jr., Esq. or Adrienne Bell, Esq. at 610.667.7706 or toll free at 844.887.9500, or you may submit your information via email at, or you may click here to print a PDF of this form.

* Denotes required field
# of Shares
Price per Share
Principal Amount
Amount Paid
Series or CUSIP
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Acadia Healthcare Company, Inc. (2018) prior to the Class Period?
Are you a current or former employee of Acadia Healthcare Company, Inc. (2018)?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC
I would like to receive
new case alerts by email